Molecular Templates, Inc. Announces Pricing of Public Offering of Common Stock

AUSTIN, Texas, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (“Molecular”), a ...

Rubius Therapeutics to Participate in the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology

CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company ...

$4.95 Bn Microbiology Testing/Clinical Microbiology Market – Global Forecast to 2023

Dublin, Sept. 20, 2018 (GLOBE NEWSWIRE) -- The "Microbiology Testing/Clinical Microbiology Market by Application ...

Portola Pharmaceuticals Names Scott Garland President and Chief Executive Officer

– Relypsa president and former Exelixis chief commercial officer brings significant commercial and operational expertise – ...